| Identifier |
20050216_nanos_controversies_03.pdf |
| Title |
Point: Counter Point: How Should the Clinically Isolated Syndrome of Optic Neuritis Be Treated? |
| Creator |
Steven Galetta, MD; Jonathan D. Trobe, MD |
| Affiliation |
Philadelphia, PA; Ann Arbor, MI |
| Subject |
Optic Neuritis; Immunomodulatory Therapy; Corticosteroids; Multiple Sclerosis; Monosymptomatic Disease |
| Description |
To: 1. Explain differences in treatment practices given the latest clinical trials; 2. Describe the risks and benefits of therapy with immunomodulatory agents; 3. Explain the risks and benefits of therapy with corticosteroids; 4. Identify the risk of developing clinically definite multiple sclerosis following a clinically isolated syndrome. |
| Date |
2005-02-16 |
| Language |
eng |
| Format |
application/pdf |
| Type |
Text |
| Source |
2005 North American Neuro-Ophthalmology Society Annual Meeting |
| Collection |
Neuro-Ophthalmology Virtual Education Library: NANOS Annual Meeting Collection: https://novel.utah.edu/collection/nanos-annual-meeting-collection/ |
| Publisher |
North American Neuro-Ophthalmology Society |
| Holding Institution |
Spencer S. Eccles Health Sciences Library, University of Utah |
| Rights Management |
Copyright 2011. For further information regarding the rights to this collection, please visit: https://NOVEL.utah.edu/about/copyright |
| ARK |
ark:/87278/s6h44xww |
| Setname |
ehsl_novel_nam |
| ID |
181279 |
| Reference URL |
https://collections.lib.utah.edu/ark:/87278/s6h44xww |
